Physician profile
Gregory Daniel Kramer
NPI 1548642234
$2,472.22
in general payments reported to CMS, 2019-2025
17 companies · $652 in 2025
The $652 reported for 2025 was more than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.21 · 2020: $134 · 2021: $178 · 2022: $372 · 2023: $551 · 2024: $531 · 2025: $652.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,734.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $840.94 | 2022-2025 | |
| Alcon Vision LLC | $523.06 | 2019-2025 | Rocklatan, Hydrus Microstent, Tryptyr |
| Allergan, INC. | $236.86 | 2020-2022 | |
| Bausch & Lomb Americas INC. | $167.94 | 2024-2025 | Vyzulta, Miebo, Xiidra |
| Thea Pharma INC. | $101.36 | 2023-2025 | Iyuzeh |
| Johnson & Johnson Surgical Vision, INC. | $97.96 | 2022-2024 | Tecnis Iol, Catalys System |
| New World Medical,INC. | $83.62 | 2023-2024 | Clearpath, Streamline, Ahmed Glaucoma Valve |
| Oyster Point Pharma, INC. | $74.47 | 2022-2025 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $72.22 | 2020-2021 | |
| Ocular Therapeutix, INC. | $58.98 | 2022-2024 | Dextenza |
| Tarsus Pharmaceuticals, INC. | $54.96 | 2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $37.34 | 2025 | |
| Mallinckrodt Hospital Products INC. | $35.21 | 2023-2025 | Acthar |
| Kala Pharmaceuticals, INC. | $31.50 | 2022 | |
| Novartis Pharmaceuticals Corporation | $27.40 | 2021-2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $15.44 | 2024 | Omni Surgical System |
| Aerie Pharmaceuticals, INC. | $12.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.